tiprankstipranks
Trending News
More News >
MediPharm Labs (TSE:LABS)
TSX:LABS
Canadian Market
Advertisement

MediPharm Labs (LABS) Technical Analysis

Compare
170 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
4Bullish
2Neutral
16Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
MediPharm Labs’s (LABS) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting MediPharm Labs is a Buy.
MediPharm Labs’s (LABS) 20-Day exponential moving average is 0.07, while MediPharm Labs’s (LABS) share price is <C$0.1, making it a Sell.
MediPharm Labs’s (LABS) 50-Day exponential moving average is 0.07, while MediPharm Labs’s (LABS) share price is <C$0.1, making it a Sell.

MediPharm Labs (LABS) Pivot Points

Sep 05, 2025, 05:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.07
0.07
0.07
0.07
0.08
0.08
Fibonacci
0.07
0.07
0.07
0.07
0.07
0.07
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MediPharm Labs (LABS) Moving Averages

Sep 05, 2025, 05:58 PM
Period
Simple
Exponential
MA5
0.07Sell
0.07Sell
MA10
0.07Sell
0.07Sell
MA20
0.07Sell
0.07Sell
MA50
0.07Sell
0.07Sell
MA100
0.08Sell
0.07Sell
MA200
0.08Sell
0.07Sell
MediPharm Labs’s (LABS) 10-Day exponential moving average is 0.07, while MediPharm Labs’s (LABS) share price is <C$0.1, making it a Sell.
MediPharm Labs’s (LABS) 100-Day exponential moving average is 0.07, while MediPharm Labs’s (LABS) share price is <C$0.1, making it a Sell.
MediPharm Labs’s (LABS) stock price is <C$0.1 and MediPharm Labs’s (LABS) 50-day simple moving average is 0.07, creating a Sell signal.
MediPharm Labs’s (LABS) stock price is <C$0.1 and MediPharm Labs’s (LABS) 100-day simple moving average is 0.08, creating a Sell signal.
MediPharm Labs’s (LABS) stock price is <C$0.1 and MediPharm Labs’s (LABS) 200-day simple moving average is 0.08, creating a Sell signal.

MediPharm Labs (LABS) Technical Indicators

Sep 05, 2025, 05:58 PM
Name
Value
Implied Action
RSI (14)
44.61
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
63.85
Sell
Williams %R
-100.00
Buy
CCI (14)
-78.25
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
27.37
Sell
ROC
-12.50
Sell
MediPharm Labs’s (LABS) Relative Strength Index (RSI) is 44.61, creating a Neutral signal.
MediPharm Labs’s (LABS) Trend Strength Indicator (ADX) is 63.85, creating a Sell signal.
MediPharm Labs’s (LABS) Commodity Channel Index (CCI) is -78.25, creating a Neutral signal.
MediPharm Labs’s (LABS) Price Rate of Change (ROC) is -12.50, creating a Sell signal.

FAQ

Is LABS a Buy, Hold, or Sell?
Based on LABS’s technical indicators, LABS is a Strong Sell.
    What is LABS’s RSI (14)?
    LABS’s RSI (14) is 44.61, which suggests LABS is a Neutral.
      What is LABS’s MACD?
      LABS’s MACD is <0.01, which suggests LABS is a Buy.
        What is LABS’s 5-day moving average?
        LABS’s 5-day moving average is 0.07, which suggests LABS is a Sell.
          What is LABS’s 20-day moving average?
          LABS 20-day moving average is 0.07, which suggests LABS is a Sell.
            What is LABS’s 50-day moving average?
            LABS’s 50-day moving average is 0.07, which suggests LABS is a Sell.
              What is LABS’s 200-day moving average?
              LABS’s 200-day moving average is 0.08, which suggests LABS is a Sell.
                What is LABS’s Williams % R (14)?
                LABS’s Williams % R (14) is -100.00, which suggests LABS is a Buy.
                  What is LABS’s CCI (14)?
                  LABS’s CCI (14) is -78.25, which suggests LABS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis